Cameco’s (CCJ) “Buy” Rating Reiterated at Glj Research

Glj Research restated their buy rating on shares of Cameco (NYSE:CCJ) (TSE:CCO) in a research note issued to investors on Wednesday,Benzinga reports. Glj Research currently has a $171.20 target price on the basic materials company’s stock, up from their prior target price of $100.00.

Other research analysts also recently issued research reports about the stock. Zacks Research upgraded shares of Cameco from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, January 14th. Raymond James Financial restated an “outperform” rating on shares of Cameco in a research note on Wednesday, January 14th. The Goldman Sachs Group reiterated a “buy” rating and set a $131.00 price target on shares of Cameco in a research report on Wednesday, February 4th. Royal Bank Of Canada raised their price objective on Cameco from $150.00 to $160.00 and gave the company an “outperform” rating in a report on Tuesday. Finally, National Bank Financial reaffirmed an “outperform” rating on shares of Cameco in a research note on Thursday, November 6th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $143.03.

Cameco Trading Up 1.8%

Shares of NYSE:CCJ opened at $121.16 on Wednesday. Cameco has a 12-month low of $35.00 and a 12-month high of $135.24. The company has a market capitalization of $52.77 billion, a PE ratio of 124.91 and a beta of 0.99. The business has a 50 day moving average of $108.78 and a two-hundred day moving average of $93.26. The company has a current ratio of 2.47, a quick ratio of 1.85 and a debt-to-equity ratio of 0.14.

Cameco (NYSE:CCJ) (TSE:CCO) last issued its quarterly earnings data on Friday, February 13th. The basic materials company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.07. Cameco had a net margin of 17.00% and a return on equity of 9.35%. The business had revenue of $874.57 million for the quarter, compared to analysts’ expectations of $782.13 million. During the same quarter last year, the company earned $0.36 EPS. The business’s revenue was up 1.5% on a year-over-year basis. As a group, analysts forecast that Cameco will post 1.27 EPS for the current year.

Hedge Funds Weigh In On Cameco

Hedge funds have recently made changes to their positions in the company. Financial Consulate Inc. purchased a new stake in shares of Cameco during the third quarter worth approximately $25,000. Nisa Investment Advisors LLC acquired a new stake in Cameco during the 4th quarter worth $25,000. Founders Capital Management purchased a new stake in shares of Cameco during the fourth quarter worth $27,000. Strategic Advocates LLC acquired a new stake in shares of Cameco in the third quarter valued at about $28,000. Finally, Mcguire Capital Advisors Inc. purchased a new position in shares of Cameco in the fourth quarter worth about $28,000. Institutional investors and hedge funds own 70.21% of the company’s stock.

Key Headlines Impacting Cameco

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: GLJ Research reiterated a buy rating on Cameco, supporting upside sentiment from some sell‑side firms that expect continued strength in uranium demand. GLJ Research Reiterates Buy for Cameco (NYSE:CCJ)
• Positive Sentiment: MarketBeat highlighted a bullish, longer-term case that global adoption of nuclear power could keep demand for uranium—and Cameco’s revenues—elevated, a thematic driver that has helped CCJ’s recent run. Can Cameco Continue Its Run?
• Neutral Sentiment: Scotiabank trimmed its FY2027 EPS forecast for Cameco slightly (from $1.53 to $1.48) but left an Outperform rating in place—this is a modest earnings haircut rather than a full-scale outlook change, so the impact may be limited unless revisions accelerate. MarketBeat: Cameco / Scotiabank Note
• Negative Sentiment: Zacks Research downgraded Cameco from “strong-buy” to “hold,” which can pressure momentum players and reduce near-term buying conviction. Zacks.com
• Negative Sentiment: There was unusually large put option activity—roughly 28,210 puts (about a 942% increase vs. average)—indicating elevated hedging or speculative bearish positioning that can amplify intraday volatility and signal downside risk if sentiment shifts. Investors Buy High Volume of Cameco Put Options

About Cameco

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.